CytRx Puts Its Cancer Pipeline to the Test

All told, the Los Angeles-based company could have six to eight trials running simultaneously in the coming months.

Read more »

CytRx to Initiate Clinical Trial for Soft Tissue Cancer Drug

CytRx, a biopharmaceutical research and development company, has announced plans to initiate a Phase II clinical trial for its drug candidate INNO-206 to treat patients who suffer from advanced, treatment-resistant soft tissue sarcoma.

Read more »